85 related articles for article (PubMed ID: 18301357)
1. Analysis of the ERalpha germline PvuII marker in breast cancer risk.
González-Mancha R; Galán JJ; Crespo C; Iglesias Pérez L; González-Perez A; Morón FJ; Moreno Nogueira JA; Real LM; Pascual MH; Ruiz A; Royo JL
Med Sci Monit; 2008 Mar; 14(3):CR136-43. PubMed ID: 18301357
[TBL] [Abstract][Full Text] [Related]
2. ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer.
Karsono R; Haryono SJ; Karsono B; Harahap WA; Pratiwi Y; Aryandono T
BMC Cancer; 2021 Dec; 21(1):1348. PubMed ID: 34930150
[TBL] [Abstract][Full Text] [Related]
3. Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis.
Zhang Y; Zhang M; Yuan X; Zhang Z; Zhang P; Chao H; Jiang L; Jiang J
Med Sci Monit; 2015 Oct; 21():2986-96. PubMed ID: 26434778
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.
Al-Amri RJ; Alotibi MKH; Al-Raddadi RI; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3235-3240. PubMed ID: 33247680
[TBL] [Abstract][Full Text] [Related]
5. Predictive polymorphisms for breast cancer in postmenopausal Mexican women.
Sierra-Martinez M; Hernández-Cadena L; García-Sánchez JR; Acosta-Altamirano G; Palacios-Reyes C; Alonso-Themann PG; García-Ortiz L; Quintas-Granados LI; Reyes-Hernández OD
J Cancer Res Ther; 2018; 14(3):640-646. PubMed ID: 29893332
[TBL] [Abstract][Full Text] [Related]
6. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
Markiewicz A; Wełnicka-Jaśkiewicz M; Skokowski J; Jaśkiewicz J; Szade J; Jassem J; Zaczek AJ
PLoS One; 2013; 8(8):e72219. PubMed ID: 23951298
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development.
Madeira KP; Daltoé RD; Sirtoli GM; Carvalho AA; Rangel LB; Silva IV
Mol Biol Rep; 2014 Aug; 41(8):5459-66. PubMed ID: 24928087
[TBL] [Abstract][Full Text] [Related]
9. The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
Houtsma D; de Groot S; Baak-Pablo R; Kranenbarg EM; Seynaeve CM; van de Velde CJH; Böhringer S; Kroep JR; Guchelaar H-; Gelderblom H
Sci Rep; 2021 Feb; 11(1):3249. PubMed ID: 33547330
[TBL] [Abstract][Full Text] [Related]
10. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
11. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
[TBL] [Abstract][Full Text] [Related]
12. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
[TBL] [Abstract][Full Text] [Related]
13. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.
Anghel A; Raica M; Narita D; Seclaman E; Nicola T; Ursoniu S; Anghel M; Popovici E
Neoplasma; 2010; 57(4):306-15. PubMed ID: 20429621
[TBL] [Abstract][Full Text] [Related]
15. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population.
Joshi G; Pradhan S; Mittal B
Cephalalgia; 2010 Mar; 30(3):311-20. PubMed ID: 19673915
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined.
Lu H; Chen D; Hu LP; Zhou LL; Xu HY; Bai YH; Lin XY
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6743-9. PubMed ID: 24377599
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of oestrogen receptor α-PvuII transition against idiopathic male infertility: a case-control study and meta-analysis.
Mobasseri N; Nikzad H; Karimian M
Reprod Biomed Online; 2019 Apr; 38(4):588-598. PubMed ID: 30738766
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
Boyapati SM; Shu XO; Ruan ZX; Cai Q; Smith JR; Wen W; Gao YT; Zheng W
Clin Cancer Res; 2005 Feb; 11(3):1093-8. PubMed ID: 15709176
[TBL] [Abstract][Full Text] [Related]
20. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
